Bioadaptives (BDPT) Assets Average (2014 - 2026)

Bioadaptives has disclosed Assets Average across 11 years of filings, most recently posting $180925.0 for Q1 2026.

• Assets Average for Q1 2026 came in at $180925.0, down 2.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $180925.0 (down 2.82% YoY), and the FY2025 annual result was $243893.0, up 33.32% from the prior year.
• Assets Average came in at $180925.0 for Q1 2026 at Bioadaptives, up from $175130.5 in the prior quarter.
• In the past five years, Assets Average ranged from a high of $216650.0 in Q4 2023 to a low of $25176.5 in Q1 2023.
• The 5-year median for Assets Average is $117828.5 (2022), against an average of $115833.0.
• Across the five-year window, Assets Average tumbled 85.4% in 2024 and soared 619.92% in 2025, its largest moves.
• Bioadaptives' Assets Average stood at $33464.5 in 2022, then soared by 547.4% to $216650.0 in 2023, then decreased by 28.85% to $154139.0 in 2024, then grew by 13.62% to $175130.5 in 2025, then grew by 3.31% to $180925.0 in 2026.
• The last three Assets Average figures came in at $180925.0 (Q1 2026), $175130.5 (Q4 2025), and $198437.5 (Q3 2025), per Business Quant data.